Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Adiponectin | 5 | ng/mL | 1 | SCF | 98.0 | 77 | ||||
N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | SCF | 84.0 | 69 | |
N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | SCF | 90.0 | 37 | |
N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | SCF | 86.5 | 64 | |
N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | SCF | 89.0 | 65 | |
N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | SCF | 71.0 | 66 | |
RA2159 | Leptin | 1 | ng/mL | 1 | SCF | 34.0 | 63 | ||||
RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | SCF | 32.0 | 53 | |
RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | SCF | 29.0 | 50 | |
RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | SCF | 33.5 | 70 | |
RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | SCF | 29.0 | 36 | |
RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | SCF | 33.0 | 38 | |
N2586 | Leptin | 1 | ng/mL | 1 | SCF | 64.0 | 33 | ||||
N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | SCF | 52.0 | 59 | |
N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | SCF | 51.0 | 55 | |
N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | SCF | 53.0 | 36 | |
N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | SCF | 53.0 | 64 | |
N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | SCF | 53.0 | 41 | |
RA2159 | 1 | SCF | 0 | ||||||||
RA2159 | PD184352 | 0.1 | uM | 1 | SCF | 0 | |||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | SCF | 0 | |||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | SCF | 0 | |||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | SCF | 0 | |||||
RA2159 | IKK16 | 2.0 | uM | 1 | SCF | 0 | |||||
RA2159 | 1 | SCF | 0 |